GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Other Stockholders Equity

CAMP (Camp4 Therapeutics) Other Stockholders Equity : $-0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Other Stockholders Equity?

Camp4 Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $-0.00 Mil.

Camp4 Therapeutics's quarterly Other Stockholders Equity stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Camp4 Therapeutics's annual Other Stockholders Equity declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($-0.00 Mil) but then increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($-0.00 Mil).


Camp4 Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Camp4 Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Other Stockholders Equity Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Other Stockholders Equity
- - -

Camp4 Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial - - - - -

Camp4 Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Camp4 Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.